BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 27008882)

  • 1. A Method for Amplicon Deep Sequencing of Drug Resistance Genes in Plasmodium falciparum Clinical Isolates from India.
    Rao PN; Uplekar S; Kayal S; Mallick PK; Bandyopadhyay N; Kale S; Singh OP; Mohanty A; Mohanty S; Wassmer SC; Carlton JM
    J Clin Microbiol; 2016 Jun; 54(6):1500-1511. PubMed ID: 27008882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next-Generation Sequencing and Bioinformatics Protocol for Malaria Drug Resistance Marker Surveillance.
    Talundzic E; Ravishankar S; Kelley J; Patel D; Plucinski M; Schmedes S; Ljolje D; Clemons B; Madison-Antenucci S; Arguin PM; Lucchi NW; Vannberg F; Udhayakumar V
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29439965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted deep amplicon sequencing of kelch 13 and cytochrome b in Plasmodium falciparum isolates from an endemic African country using the Malaria Resistance Surveillance (MaRS) protocol.
    L'Episcopia M; Kelley J; Patel D; Schmedes S; Ravishankar S; Menegon M; Perrotti E; Nurahmed AM; Talha AA; Nour BY; Lucchi N; Severini C; Talundzic E
    Parasit Vectors; 2020 Mar; 13(1):137. PubMed ID: 32171330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multiplex ligase detection reaction-fluorescent microsphere assay for simultaneous detection of single nucleotide polymorphisms associated with Plasmodium falciparum drug resistance.
    Carnevale EP; Kouri D; DaRe JT; McNamara DT; Mueller I; Zimmerman PA
    J Clin Microbiol; 2007 Mar; 45(3):752-61. PubMed ID: 17121999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Plasmodium falciparum genes associated with drug resistance in Hodh Elgharbi, a malaria hotspot near Malian-Mauritanian border.
    Ould Ahmedou Salem MS; Mint Lekweiry K; Bouchiba H; Pascual A; Pradines B; Ould Mohamed Salem Boukhary A; Briolant S; Basco LK; Bogreau H
    Malar J; 2017 Apr; 16(1):140. PubMed ID: 28381273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted deep amplicon sequencing of antimalarial resistance markers in Plasmodium falciparum isolates from Cameroon.
    L'Episcopia M; Kelley J; Djeunang Dongho BG; Patel D; Schmedes S; Ravishankar S; Perrotti E; Modiano D; Lucchi NW; Russo G; Talundzic E; Severini C
    Int J Infect Dis; 2021 Jun; 107():234-241. PubMed ID: 33940188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of sulfadoxine-pyrimethamine resistance in Indian isolates of Plasmodium falciparum in the last two decades.
    Kumar A; Moirangthem R; Gahlawat SK; Chandra J; Gupta P; Valecha N; Anvikar A; Singh V
    Infect Genet Evol; 2015 Dec; 36():190-198. PubMed ID: 26319997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphisms associated with sulphadoxine-pyrimethamine drug resistance among Plasmodium falciparum field isolates in malaria endemic areas of Assam.
    Sharma J; Dutta P; Khan SA; Soni M; Dey D; Mahanta J
    J Postgrad Med; 2015; 61(1):9-14. PubMed ID: 25511211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Malaria TaqMan Array Card Includes 87 Assays for Plasmodium falciparum Drug Resistance, Identification of Species, and Genotyping in a Single Reaction.
    Pholwat S; Liu J; Stroup S; Jacob ST; Banura P; Moore CC; Huang F; Laufer MK; Houpt E; Guler JL
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of targeted next-generation sequencing for Plasmodium falciparum drug resistance markers.
    Kunasol C; Dondorp AM; Batty EM; Nakhonsri V; Sinjanakhom P; Day NPJ; Imwong M
    Sci Rep; 2022 Apr; 12(1):5563. PubMed ID: 35365711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-grade sulfadoxine-pyrimethamine resistance in Plasmodium falciparum parasites from Lubango, Angola.
    Kaingona-Daniel EP; Gomes LR; Gama BE; Almeida-de-Oliveira NK; Fortes F; Ménard D; Daniel-Ribeiro CT; Ferreira-da-Cruz Mde F
    Malar J; 2016 Jun; 15():309. PubMed ID: 27267365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequencies distribution of dihydrofolate reductase and dihydropteroate synthetase mutant alleles associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum population from Hadhramout Governorate, Yemen.
    Bamaga OA; Mahdy MA; Lim YA
    Malar J; 2015 Dec; 14():516. PubMed ID: 26693691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a parasite-density based pooled targeted amplicon deep sequencing (TADS) method for molecular surveillance of Plasmodium falciparum drug resistance genes in Haiti.
    Louha S; Herman C; Gupta M; Patel D; Kelley J; Oh JM; Guru J; Lemoine JF; Chang MA; Venkatachalam U; Rogier E; Talundzic E
    PLoS One; 2022; 17(1):e0262616. PubMed ID: 35030215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pooled deep sequencing of Plasmodium falciparum isolates: an efficient and scalable tool to quantify prevailing malaria drug-resistance genotypes.
    Taylor SM; Parobek CM; Aragam N; Ngasala BE; MÃ¥rtensson A; Meshnick SR; Juliano JJ
    J Infect Dis; 2013 Dec; 208(12):1998-2006. PubMed ID: 23908494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of sulphadoxine-pyrimethamine resistance-associated mutations in Plasmodium falciparum field isolates from pregnant women in Brazzaville, Republic of Congo.
    Koukouikila-Koussounda F; Bakoua D; Fesser A; Nkombo M; Vouvoungui C; Ntoumi F
    Infect Genet Evol; 2015 Jul; 33():32-6. PubMed ID: 25934142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High chloroquine treatment failure rates and predominance of mutant genotypes associated with chloroquine and antifolate resistance among falciparum malaria patients from the island of Car Nicobar, India.
    Das MK; Lumb V; Mittra P; Singh SS; Dash AP; Sharma YD
    J Antimicrob Chemother; 2010 Jun; 65(6):1258-61. PubMed ID: 20363804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Plasmodium falciparum Molecular Markers of Antimalarial Drug Resistance in a Residual Malaria Focus Area in Sabah, Malaysia.
    Norahmad NA; Mohd Abd Razak MR; Abdullah NR; Sastu UR; Imwong M; Muniandy PK; Saat MN; Muhammad A; Jelip J; Tikuson M; Yusof N; Rundi C; Mudin RN; Syed Mohamed AF
    PLoS One; 2016; 11(10):e0165515. PubMed ID: 27788228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of amplicon deep sequencing markers and data analysis pipeline for genotyping multi-clonal malaria infections.
    Lerch A; Koepfli C; Hofmann NE; Messerli C; Wilcox S; Kattenberg JH; Betuela I; O'Connor L; Mueller I; Felger I
    BMC Genomics; 2017 Nov; 18(1):864. PubMed ID: 29132317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive increase in point mutations associated with chloroquine resistance in Plasmodium falciparum isolates from India.
    Mittra P; Vinayak S; Chandawat H; Das MK; Singh N; Biswas S; Dev V; Kumar A; Ansari MA; Sharma YD
    J Infect Dis; 2006 May; 193(9):1304-12. PubMed ID: 16586369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of pfdhfr-pfdhps triple mutations associated with anti-malarial drugs resistance in Plasmodium falciparum isolates seven years after the adoption of sulfadoxine-pyrimethamine in combination with artesunate as first-line treatment in Iran.
    Rouhani M; Zakeri S; Pirahmadi S; Raeisi A; Djadid ND
    Infect Genet Evol; 2015 Apr; 31():183-9. PubMed ID: 25653131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.